Sign In
Buy CARA
$5.32
+0 (+0%)
At Close: Jul 14, 2025
Cara Therapeutics Reports Third Quarter 2023 Financial Results
04:01pm, Monday, 13'th Nov 2023
– Non-dilutive financing agreement with HealthCare Royalty for up to $40 million expected to extend cash runway into 2025 –
Earnings Preview: Cara Therapeutics (CARA) Q3 Earnings Expected to Decline
11:17am, Monday, 06'th Nov 2023
Cara (CARA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cara Therapeutics Announces up to $40.0 Million Non-Dilutive Financing Agreement with HealthCare Royalty
07:00am, Thursday, 02'nd Nov 2023
Transaction supports progression of late-stage oral difelikefalin clinical programs Non-dilutive capital expected to extend cash runway into 2025 STAMFORD, Conn., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Car
Cara Therapeutics to Announce Third Quarter 2023 Financial Results on November 13, 2023
07:00am, Monday, 23'rd Oct 2023
STAMFORD, Conn., Oct. 23, 2023 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patien
Cara Therapeutics (CARA) Reports Q2 Loss, Tops Revenue Estimates
06:54pm, Monday, 07'th Aug 2023
Cara Therapeutics (CARA) came out with a quarterly loss of $0.58 per share versus the Zacks Consensus Estimate of a loss of $0.56. This compares to loss of $0.08 per share a year ago.
Cara Therapeutics, Inc. (CARA) Q2 2023 Earnings Call Transcript
06:13pm, Monday, 07'th Aug 2023
Cara Therapeutics, Inc. (NASDAQ:CARA ) Q2 2023 Earnings Conference Call August 7, 2023 4:30 PM ET Company Participants Matthew Murphy - Manager, IR Christopher Posner - President, CEO & Director Ryan
Cara Therapeutics to Announce Second Quarter 2023 Financial Results on August 7, 2023
07:00am, Monday, 24'th Jul 2023
STAMFORD, Conn., July 24, 2023 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patien
Cara Therapeutics Faces Uncertainty Despite Potential Reimbursement Extension For Korsuva
05:11pm, Friday, 14'th Jul 2023
Cara Therapeutics' Korsuva injection, approved for treating pruritus in adults with chronic kidney disease, may have its reimbursement period extended to 2027 by the US Medicare and Medicaid Services,
3 Small-Cap Stocks to Sell in June Before They Crash and Burn
06:30am, Tuesday, 13'th Jun 2023
Small-cap stocks, defined by a market capitalization between $300 million and $2 billion, can tempt investors looking for quick returns. However, these small-cap stocks to avoid can be incredibly vola
Cara Therapeutics to Present at the Jefferies Healthcare Conference
07:00am, Thursday, 01'st Jun 2023
STAMFORD, Conn., June 01, 2023 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patien
7 Stocks With 1,000% Upside Potential
06:34pm, Tuesday, 30'th May 2023
While market advocates will wince at accusations that investing is nothing more than legalized gambling, for these stocks with massive upside potential, I for one will have to concede that only specul
Cara Therapeutics, Inc. (CARA) Q1 2023 Earnings Call Transcript
07:31pm, Monday, 15'th May 2023
Cara Therapeutics, Inc. (NASDAQ:CARA ) Q1 2023 Earnings Conference Call May 15, 2023 4:30 PM ET Company Participants Matt Murphy - Manager, IR Christopher Posner - CEO Ryan Maynard - CFO Dr. Joana Gon
Cara Therapeutics (CARA) Reports Q1 Loss, Tops Revenue Estimates
06:59pm, Monday, 15'th May 2023
Cara Therapeutics (CARA) came out with a quarterly loss of $0.49 per share versus the Zacks Consensus Estimate of a loss of $0.53. This compares to loss of $0.52 per share a year ago.
Cara Therapeutics, Inc. (CARA) to Announce First Quarter 2023 Financial Results on May 15, 2023
09:20am, Monday, 01'st May 2023
Cara Therapeutics to Announce First Quarter 2023 Financial Results on May 15,
Cara Therapeutics to Announce First Quarter 2023 Financial Results on May 15, 2023
07:00am, Monday, 01'st May 2023
STAMFORD, Conn., May 01, 2023 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patient
